CESTAT Bangalore: 'Aswini Homeo Arnica Hair Oil' classified as medicament, waiver granted

The Appellate Tribunal CESTAT Bangalore ruled in favor of the appellant, a manufacturer of homeopathy medicines, regarding the classification of 'Aswini Homeo Arnica Hair Oil' as a medicament rather than a cosmetic product. The tribunal found the presence of homeopathic medicaments, absence of perfume, and specific usage indications supported the classification as a medicament. Additionally, the tribunal granted a waiver of pre-deposit due to the appellant's financial difficulties and the unique circumstances of the case, providing relief during the proceedings with a stay against recovery for 180 days.

---

---

Issues: Classification of product as cosmetic or medicament, waiver of pre-deposit

Classification Issue Analysis:
The appellant, engaged in manufacturing homeopathy medicines, faced proceedings regarding the classification of 'Aswini Homeo Arnica Hair Oil' as either a cosmetic or a medicament under CETH 33. The appellant argued that the product should be classified as a medicament, supported by the presence of homeopathic medicaments like Arnica Mount, Cantharis, Pilocarpin, and Cinchona, which aid in preventing hair fall and dandruff. The product label indicated usage for preventing hair fall and dandruff, without mentioning it as a hair oil. The absence of perfume and the recommendation to apply it to the scalp and leave it overnight supported the appellant's claim. The Tribunal found these distinctions significant, making the product a distinct medicament rather than a conventional hair oil. The appellant also presented evidence of financial difficulties, further strengthening their case for classification as a medicament.

Waiver of Pre-Deposit Analysis:
The appellant contended that previous final decisions had accepted the classification as a medicament, and the current reopening of the issue was unjustified. The Tribunal acknowledged the need for a detailed examination of past cases and records, which was not feasible at that stage. Considering the unique factors of the case and the distinctions from cited precedents, the Tribunal found that the appellant had established a prima facie case for waiver of pre-deposit. Consequently, the requirement for pre-deposit was waived, and a stay against recovery was granted for 180 days from the date of the order, providing relief to the appellant during the ongoing proceedings.

This judgment from the Appellate Tribunal CESTAT Bangalore delves into the intricate classification issue of a product manufactured by the appellant, emphasizing the presence of homeopathic medicaments and usage indications to differentiate it from a cosmetic product. Additionally, the decision to waive pre-deposit showcases the Tribunal's consideration of the unique circumstances and the appellant's prima facie case, ensuring a fair approach to the ongoing dispute.

---